| Target Price | HK$38.48 |
| Price | HK$32.60 |
| Potential |
18.05%
register free of charge
|
| Number of Estimates | 26 |
|
26 Analysts have issued a price target WuXi Biologics 2026 .
The average WuXi Biologics target price is HK$38.48.
This is
18.05%
register free of charge
HK$54.60
67.48%
register free of charge
HK$30.30
7.06%
register free of charge
|
|
| A rating was issued by 33 analysts: 27 Analysts recommend WuXi Biologics to buy, 6 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the WuXi Biologics stock has an average upside potential 2026 of
18.05%
register free of charge
|
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Billion HK$ | 20.68 | 24.33 |
| 9.63% | 17.66% | |
| EBITDA Margin | 33.56% | 36.00% |
| 7.52% | 7.28% | |
| Net Margin | 17.97% | 21.28% |
| 9.96% | 18.42% |
29 Analysts have issued a sales forecast WuXi Biologics 2025 . The average WuXi Biologics sales estimate is
This results in the following potential growth metrics:
30 WuXi Biologics Analysts have issued a net profit forecast 2025. The average WuXi Biologics net profit estimate is
This results in the following potential growth metrics and future Net Margins:
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share HK$ | 0.87 | 1.27 |
| 0.00% | 45.98% | |
| P/E | 25.62 | |
| EV/Sales | 5.23 |
30 Analysts have issued a WuXi Biologics forecast for earnings per share. The average WuXi Biologics EPS is
This results in the following potential growth metrics and future valuations:
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


